| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
18,299 |
15,763 |
$2.79M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,440 |
5,427 |
$189K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,450 |
6,598 |
$155K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,972 |
2,441 |
$47K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
689 |
513 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
468 |
276 |
$9K |
| 90686 |
|
452 |
344 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
238 |
142 |
$3K |
| 92551 |
|
326 |
188 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
58 |
31 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
60 |
36 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$855.19 |
| 90651 |
|
12 |
12 |
$539.68 |
| 85018 |
|
419 |
254 |
$500.39 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
30 |
16 |
$393.75 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
62 |
60 |
$382.70 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
58 |
38 |
$349.24 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15 |
14 |
$346.50 |
| 81003 |
|
279 |
170 |
$340.32 |
| 90656 |
|
14 |
14 |
$263.07 |
| 90647 |
|
67 |
40 |
$210.22 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
25 |
$192.93 |
| 90670 |
|
46 |
26 |
$155.38 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
29 |
16 |
$139.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
72 |
67 |
$102.58 |
| 90723 |
|
24 |
14 |
$73.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
22 |
14 |
$64.40 |
| 90680 |
|
22 |
13 |
$63.98 |
| 99173 |
|
27 |
13 |
$32.11 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
36 |
24 |
$0.16 |
| 3078F |
|
79 |
77 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
32 |
16 |
$0.00 |
| 3079F |
|
90 |
90 |
$0.00 |
| 3074F |
|
150 |
145 |
$0.00 |
| 88738 |
|
19 |
13 |
$0.00 |